Content about Alliance Boots

December 10, 2012

DSN looks back on the past year's most influential events in the pharmacy industry, from Obamacare and record patent expirations to Humira surpassing Lipitor as the world's top-selling drug and the merger of Walgreens and Alliance Boots.

DSN looks back on the past year's most influential events in the pharmacy industry, from Obamacare and record patent expirations to Humira surpassing Lipitor as the world's top-selling drug and the merger of Walgreens and Alliance Boots.

 

October 9, 2012

In part 2 of his exclusive interview with Walgreens executives, DSN editor Rob Eder talks to Walgreens president and CEO Greg Wasson about how the company’s recent acquisition of Alliance Boots helps accelerate the massive transformation that is already under way across its business and its stores.

In part 2 of his exclusive interview with Walgreens executives, DSN editor Rob Eder talks to Walgreens president and CEO Greg Wasson about how the company’s recent acquisition of Alliance Boots helps accelerate the massive transformation that is already under way across its business and its stores. Part of the DSN.TV Executive Viewpoint series, the special three-part installment is sponsored by Jubilant Cadista Pharmaceuticals. Coming next week in part 3, DSN.TV talks to president of health and daily living products and solutions Joe Magnacca.

February 18, 2014

Recent strategic business initiatives are granting wholesalers more generic drug purchasing power than ever before.

Recent strategic business initiatives are granting wholesalers more generic drug purchasing power than ever before.

Over the last few years, some major deals in the world of drug wholesaling have taken shape. While the business arrangements among the three top wholesalers differ slightly in terms of ownership, benefits and risks, one thing is for certain: all of the agreements will translate into growth opportunities for the companies involved and will help them improve their generic drug sourcing practices.

January 31, 2014

If you don't succeed the first time, try, try again. That's exactly what McKesson did when it announced that it reached an agreement with Franz Haniel & Cie. GmbH to acquire its entire holding of Celesio shares. And in a separate and subsequent agreement, McKesson also picked up the Celesio convertible bonds from Elliott.

Nothing good is ever easy. "While the path to securing this acquisition was certainly not what we had originally expected, it would seem that the interested parties to this transaction continued to see the compelling strategic benefit of McKesson and Celesio uniting to form a global leader in health care services," John Hammergren, McKesson chairman, CEO and president, said of the deal. "I never lost sight of the value this transaction will bring to our customers, our supply chain partners, the employees of both organizations and our shareholders."

If you don't succeed the first time, try, try again. That's exactly what McKesson did when it announced that it reached an agreement with Franz Haniel & Cie. GmbH to acquire its entire holding of Celesio shares. And in a separate and subsequent agreement, McKesson also picked up the Celesio convertible bonds from Elliott.

January 8, 2014

Walgreens is not only completely transforming its drug store business from a prescription medicine dispensary to healthcare provider, they're continuing to deliver shareholder value.

CHICAGO — Walgreens is not only completely transforming its drug store business from a prescription medicine dispensary to healthcare provider, they're continuing to deliver shareholder value. Since the chain implemented its "Plan to Win" strategy five years ago, kicking off Walgreens journey to reinvent and innovate the storied drug store chain for a new era of growth and value creation, Walgreens has delivered 145% in shareholder returns vs. the 118% return realized by the S&P 500 in the same period. 

December 13, 2013

Alliance Boots is expanding its network of independent pharmacists operating under the Alphega Pharmacy banner, according to a report published by RetailWeek Friday.

LONDON — Alliance Boots is expanding its network of independent pharmacists operating under the Alphega Pharmacy banner, according to a report published by RetailWeek Friday

December 12, 2013

Following reports in the media in Mexico and Chile of discussions between Alliance Boots and Grupo Casa Saba and its shareholders, Alliance Boots confirmed that it has stopped all discussions.

ZUG, Switzerland — Following reports in the media in Mexico and Chile of discussions between Alliance Boots and Grupo Casa Saba and its shareholders, Alliance Boots on Wednesday confirmed that it has stopped all discussions with Casa Saba and its shareholders in connection with an investment in Casa Saba or a purchase of certain of Casa Saba’s assets. 

Alliance Boots' decision not to invest has been based on its inability to determine the current financial situation of Casa Saba, the company reported. 

November 5, 2013

Walgreens and Alliance Boots on Tuesday announced that Richard Ashworth, Walgreens corporate operations VP for the Western United States, has been appointed as director of health care, health and beauty U.K. and Republic of Ireland at Alliance Boots.

DEERFIELD, Ill. — Walgreens and Alliance Boots on Tuesday announced that Richard Ashworth, Walgreens corporate operations VP for the Western United States, has been appointed as director of health care, health and beauty U.K. and Republic of Ireland at Alliance Boots. He will report to Simon Roberts, managing director, health and beauty U.K. and ROI.

October 25, 2013

With is proposed acquisition of German wholesaler Celesio, McKesson creates a global distribution enterprise on the scale of Walgreens, Alliance Boots and AmerisourceBergen before them. In addition to wholesaling, Celesio operates about 2,200 pharmacies across six countries and is the No. 2 operator in the United Kingdom.

Retail pharmacy and drug sourcing both are more and more becoming a global business. Just last week, the head of the second-biggest drug chain in Brazil announced he would be open to a buyout. So expect more of these headlines in the months to come.

With is proposed acquisition of German wholesaler Celesio, McKesson creates a global distribution enterprise on the scale of Walgreens, Alliance Boots and AmerisourceBergen before them. In addition to wholesaling, Celesio operates about 2,200 pharmacies across six countries and is the No. 2 operator in the United Kingdom. 

October 24, 2013

McKesson on Thursday confirmed its proposed acquisition of Celesio, a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors, with an agreement to acquire a majority stake in Celesio for €23 per share (US$31.75 per share) and to launch parallel voluntary public tender offers for the remaining publicly traded shares and outstanding convertible bonds of Celesio.

SAN FRANCISCO — McKesson on Thursday confirmed its proposed acquisition of Celesio, a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors, with an agreement to acquire a majority stake in Celesio for €23 per share (US$31.75 per share) and to launch parallel voluntary public tender offers for the remaining publicly traded shares and outstanding convertible bonds of Celesio.  

October 1, 2013

Walgreens posted a sales gain of 0.8% for the fiscal year ended Aug. 31, reaching a record $72.2 billion and filling a record 821 million prescriptions.

DEERFIELD, Ill. — Walgreens posted a sales gain of 0.8% for the fiscal year ended Aug. 31, reaching a record $72.2 billion and filling a record 821 million prescriptions. That volume of prescriptions filled helped Walgreens boost its retail pharmacy market share for the fiscal year to 19.1%. 

Early morning trading boosted Walgreens' share price from a close of $53.80 on Monday to $56.06, an increase of 4.2%.

September 20, 2013

Alliance Boots announced that it is establishing a specialized investment fund, B&B Capital Partners, which will be focused on small- and medium-sized consumer brand businesses within the health, wellness, beauty and personal care sectors.

BERN, Switzerland — Alliance Boots on Friday announced that it is establishing a specialized investment fund, B&B Capital Partners, which will be focused on small- and medium-sized consumer brand businesses within the health, wellness, beauty and personal care sectors.  

The fund will be managed by B&B Investment Partners, a new partnership between Alliance Boots and the two principals of B&B Investment Partners, Chris Britton and Jean-Philippe Barade.

August 19, 2013

Walgreens last week made several executive moves to boost its Daily Living business organization, chief of which was the announcement that Alex Gourlay will make the transition from chief executive of Alliance Boots' health and beauty division to EVP, president of customer experience and daily living for Walgreens. http://www.drugstorenews.com/article/walgreens-announces-enhanced-daily-...

Gorley will fill in the vision and leadership hole Joe Magnacca left when he departed Walgreens to take on challenge of reinventing Radio Shack. The move showcases the kind of extended depth chart that is now enjoyed across Walgreens and Alliance Boots and takes Walgreens' strategy of tapping the best executives to fill strategic positions to a whole new global level.

Walgreens last week made several executive moves to boost its Daily Living business organization, chief of which was the announcement that Alex Gourlay will make the transition from chief executive of Alliance Boots' health and beauty division to EVP, president of customer experience and daily living for Walgreens. 

August 14, 2013

Walgreens announced an enhanced Daily Living business organization with the promotion and leadership expansion of key marketing and merchandising executives.

DEERFIELD, Ill. — Walgreens on Wednesday announced an enhanced Daily Living business organization with the promotion and leadership expansion of key marketing and merchandising executives to further accelerate the company’s strategic growth drivers and advance its vision to be the first choice in health and daily living for everyone in America, and beyond.

July 23, 2013

Skin care brand Indeed Laboratories is bringing its nanoblur and snoxin skin care products to the U.S. market, through distributor Boots USA, with exclusive availability at Walgreens and Duane Reade stores.

NEW YORK & DEERFIELD, Ill. — Skin care brand Indeed Laboratories is bringing its nanoblur and snoxin skin care products to the U.S. market, through distributor Boots USA, with exclusive availability at Walgreens and Duane Reade stores. The brand’s U.S. retail launch is the result of the partnership formed last summer between Alliance Boots and Walgreens.

June 21, 2013

No7 Men skin care products, part of the U.K.’s skin care brand No7 created by Boots, is now available chainwide at Walgreens and Duane Reade stores.

NEW YORK & DEERFIELD, Ill. — No7 Men skin care products, part of the U.K.’s skin care brand No7 created by Boots, is now available chainwide at Walgreens and Duane Reade stores.

The debut marks the first nationwide Boots product launch for Walgreens with Alliance Boots since the two companies formed a strategic partnership last summer to create a global pharmacy-led, health and wellbeing enterprise. No7 is known for its range of skin care products.

May 17, 2013

Alliance Boots posted a double-digit adjusted profit gain of 12.7% to $1.2 billion for its year ended March 31. Almost half of that profit is staked by Walgreens with its 45% share of the European pharmaceutical distributing powerhouse.

A couple days later, Alliance Boots along with Walgreens and AmerisourceBergen announced the necessary regulatory clearances on that strategic partnership, cementing the three companies in place as the largest generic pharmaceutical acquisition company in the world. That deal will further enable the company's to realize greater profit margins.

Alliance Boots posted a double-digit adjusted profit gain of 12.7% to $1.2 billion for its year ended March 31. Almost half of that profit is staked by Walgreens with its 45% share of the European pharmaceutical distributing powerhouse. 

May 17, 2013

The deal that paired Walgreens and Alliance Boots with wholesaler AmerisourceBergen has received the required regulatory clearances, the companies announced Friday.

DEERFIELD, Ill. — The deal that paired Walgreens and Alliance Boots with wholesaler AmerisourceBergen has received the required regulatory clearances, the companies announced Friday. 

The regulatory clearances permit both Walgreens and Alliance Boots the purchase of up to 7% of the fully diluted equity of AmerisourceBergen in the open market, and the exercise of two warrants for 16% in the aggregate of the fully diluted equity of AmerisourceBergen in 2016 and 2017. 

May 15, 2013

Alliance Boots on Wednesday reported a double-digit profit gain for its year ended March 31.

BERN, Switzerland — Alliance Boots on Wednesday reported a double-digit profit gain for its year ended March 31. Underlying profit after tax was up 12.7% to $1.2 billion, though revenue was down slightly by 2.6% to $34.2 billion. 

May 10, 2013

Alliance Boots on Friday announced that it has distributed its equity interest in Galenica, its Swiss associate, to the group’s ultimate parent company, AB Acquisitions Holdings, in accordance with the terms of the agreement with Walgreens reached last year.

BERN, Switzerland — Alliance Boots on Friday announced that it has distributed its equity interest in Galenica, its Swiss associate, to the group’s ultimate parent company, AB Acquisitions Holdings, in accordance with the terms of the agreement with Walgreens reached last year.

Galenica continues as an associate of AB Acquisitions Holdings. Stefano Pessina, executive chairman of Alliance Boots, continues as non-executive director of Galenica while Etienne Jornod, executive chairman of Galenica, stays as a non-executive director of Alliance Boots.

April 26, 2013

Cardinal Health announced the renewal of its pharmaceutical distribution agreement with CVS Caremark to supply pharmaceuticals to the company’s retail pharmacies and distribution centers, as McKesson, which generally serves the PBM side of the business, also announced the renewal of its current distribution agreement with the pharmacy retailer.

The renewal of the agreements was not only critical for both companies but, as Adam Fein, president of Pembroke Consulting and CEO of Drug Channels Institute, wrote in his blog “CVS Caremark Renews with Cardinal and McKesson,” it also “demonstrates wholesalers' value in the brand-name pharmacy supply chain.”

Cardinal Health announced the renewal of its pharmaceutical distribution agreement with CVS Caremark to supply pharmaceuticals to the company’s retail pharmacies and distribution centers, as McKesson, which generally serves the PBM side of the business, also announced the renewal of its current distribution agreement with the pharmacy retailer.

April 26, 2013

AmerisourceBergen's base of 3,452 independently owned Good Neighbor Pharmacies will be another benefactor out of the wholesaler's blockbuster agreement with Walgreens and Alliance Boots, AmerisourceBergen CEO, president, director and chairman Steven Collis told analysts during a conference call Thursday.

VALLEY FORGE, Pa. — AmerisourceBergen's base of 3,452 independently owned Good Neighbor Pharmacies will be another benefactor out of the wholesaler's blockbuster agreement with Walgreens and Alliance Boots, AmerisourceBergen CEO, president, director and chairman Steven Collis told analysts during a conference call Thursday.

April 22, 2013

To the skepticism of many, Walgreens last year made a big global splash with its two-step merger deal with Alliance Boots across the pond. But with the announcement that the co-joined Walgreens/Alliance Boots had signed a 10-year distribution deal with wholesaler AmerisourceBergen, that included an equity stake to boot, well, it seemed that many analysts on Wall Street finally got it.

To the skepticism of many, Walgreens last year made a big global splash with its two-step merger deal with Alliance Boots across the pond. But with the announcement that the co-joined Walgreens/Alliance Boots had signed a 10-year distribution deal with wholesaler AmerisourceBergen, that included an equity stake to boot, well, it seemed that many analysts on Wall Street finally got it.

April 21, 2013

It's official. During its most recent quarterly conference call with analysts, CVS Caremark revealed what many had anticipated: Its acquisition of privately held Brazilian drug store chain Drogaria Onofre was complete.

It's official. During its most recent quarterly conference call with analysts, CVS Caremark revealed what many had anticipated: Its acquisition of privately held Brazilian drug store chain Drogaria Onofre was complete.

The move is not financially material to CVS Caremark, but it does mark its first foray into the international drug store space. The 44-store chain is the eighth-largest drug store chain in Brazil and, according to published reports, posted gross revenue of R$1.2 billion (Brazilian reals) in 2011.

March 27, 2013

Alliance Boots on Wednesday announced its contract manufacturing business BCM will invest heavier into core competency categories, such as beauty and skin care, as it discontinues third-party manufacturer development in unnamed "unprofitable" categories.

LONDON — Alliance Boots on Wednesday announced its contract manufacturing business BCM will invest heavier into core competency categories, such as beauty and skin care, as it discontinues third-party manufacturer development in unnamed "unprofitable" categories.